Phase 2 Hypertension Trial, Recruiting NCT06634069 Sponsor: University Hospital Pilsen Condition: Hypertension
Back to Hypertension

Phase 2 Hypertension Trial, Recruiting

NCT06634069
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 90 years old
  • People diagnosed with septic shock, meaning they have a serious infection that has caused a significant decline in organ function, require medication to keep their blood pressure stable, and have had an elevated blood lactate level (a sign of poor circulation) within the last 24 hours
  • People showing signs that their body is not circulating blood well enough, such as poor blood flow to the hands and feet, low urine output, low oxygen levels in the blood, or confusion — with at least 2 of these 4 signs present
  • People whose body is likely to respond to receiving extra fluids, as confirmed by one of several specific bedside tests measuring how the heart responds to fluid (confirm with trial site for details on these tests)
  • People who have signed the relevant consent form agreeing to take part in the trial

Who may not be able to join:

  • People whose heart cannot be clearly seen using an ultrasound scan through the chest wall
  • People whose actual body weight is more than 160 kg
  • People with sodium levels in the blood that are too high (above 150 mEq/L)
  • People with a condition called cardiac tamponade, where fluid around the heart is putting dangerous pressure on it
  • People with serious uncorrected heart valve disease or a life-threatening irregular heartbeat
  • People who are expected to pass away before the trial procedures could be completed
  • People who urgently need kidney dialysis or blood filtration within 2 hours due to dangerously low blood acidity or very high potassium levels
  • People with severe liver dysfunction, indicated by a very high bilirubin level in the blood (above 120 umol/L)
  • People who are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +420732850912

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
University Hospital Pilsen
Registry
ClinicalTrials.gov
Start date
24 November 2024
Est. completion
31 October 2027

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

haemodynamic effects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov